Albagli Zaliasnik

Home to ‘excellent lawyers who have extensive industry experience’, Albagli Zaliasnik's multidisciplinary regulatory and life sciences group is routinely sought out by major national and international pharmaceutical companies. The six-strong team, which comprises both lawyers and technical expert, covers biotechnology, pharmaceutical products, medical devices, cosmetics, food processing regulation, compliance, investigations, pharmaceutical litigation, technology transfer, public tenders, clinical trials and advertising. The firm also has a notable track record in pharmaceutical industry-related patent infringement cases, cancellation actions, and regulatory disputes; and regularly represents clients in administrative proceedings before Chile’s health, competition and IP authorities. Examples of mandates include advising multinational medical devices and healthcare company, Abbott, on the application of the public policy of bioequivalence to pharmaceutical products. Ariela Agosin leads the firm’s civil and arbitration, life sciences and public law and regulated markets groups; and IP, technology and data team head Eugenio Gormáz advises on life sciences, plant varieties, IP, cybersecurity, e-commerce, AI, and denominations of origin and geographical indications. Beyond the partnership, the experience of life sciences and competition director Dafne Guerra includes regulatory matters, consumer and advertising law, regulatory compliance, antitrust, patent litigation, health and safety regulation, and dispute resolution. At associate level Francisco Alarcón's wide-ranging expertise extends to the pharmaceutical industry.